BMRN vs UNIT · P/E 40, rev $2.85B vs P/E 2.7, rev $722.6M
Biomarin Pharmaceutical Inc (BMRN) versus Uniti Group Inc (UNIT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Not investment advice. Open the BMRN and UNIT stock pages for the full models.
Not investment advice.